NEW YORK — Fera Pharmaceuticals on Monday announced that it was selected by Pragma Pharmaceuticals to launch amoxicillin extended-release tablets, the authorized generic version of Moxatag.
“By having an authorized generic available, it is our hope that more patients will gain access to this once-a-day antibiotic therapy helping to ensure greater adherence and compliance," Craig Salmon, VP of sales at Fera, said.